市場調查報告書
商品編碼
1410882
膽固醇測試市場:市場規模(按細分市場)、份額、監管、報銷、預測(~2033 年)Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
進行膽固醇測試是為了檢查血液中膽固醇水平是否升高。 血液膽固醇水平升高會增加心臟病、中風和周邊動脈疾病的風險。 高血壓的盛行率是最大的因素之一。
測量血液膽固醇有幾個參數,包括高密度脂蛋白(HDL)、低密度脂蛋白(LDL)和總膽固醇。 HDL 是 "好膽固醇" 的標記,而 LDL 是 "壞膽固醇" 的標記。 總膽固醇是血液中膽固醇的總量,包括 "好" 膽固醇和 "壞" 膽固醇。
膽固醇檢測模式分為高密度脂蛋白(HDL)膽固醇檢測、低密度脂蛋白(LDL)膽固醇檢測、總膽固醇檢測、多參數膽固醇檢測。
本報告深入探討了全球膽固醇檢測市場,提供競爭格局、SWOT 分析、到 2033 年的市場預測、COVID-19 的影響、區域和國家趨勢等。Masu。
Cholesterol Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033 is built to visualize quantitative market trends within In Vitro Diagnostics therapeutic area.
The model discusses in detail the impact of COVID-19 on Cholesterol Tests market for the year 2020 and beyond. Cholesterol test is performed to identify elevated levels of cholesterol present in the blood. Elevated levels of cholesterol in the blood may increase the risk of heart attack, stroke, and peripheral artery disease. The prevalence of hypertension is one of the largest drivers.
There are a few parameters for the determination of cholesterol in the blood, such as high-density lipoproteins (HDL), low-density lipoproteins (LDL), and total cholesterol. HDL is a marker of "good cholesterol", whereas LDL is known as a marker of "bad cholesterol"; total cholesterol is the overall amount of cholesterol in the blood, including both "good" and "bad" cholesterols.
Cholesterol Tests model is segmented into High-Density Lipoprotein (HDL) Cholesterol Lab Tests, Low-Density Lipoprotein (LDL) Cholesterol Test, Total Cholesterol Test and Multi-parameter Cholesterol Test.
Each of the covered 39 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.
Key Inclusions of the market model are:
Currently marketed Cholesterol Tests and evolving competitive landscape:
Global, Regional and Country level market specific insights:
Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition, the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.
Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.
Companies covered: Abbott Laboratories, Danaher Corp, Helena Laboratories Corp, QuidelOrtho Corp, F. Hoffmann-La Roche Ltd, Siemens AG, Thermo Fisher Scientific Inc, Randox Laboratories Ltd, Sekisui Chemical Ltd, Alfa Wassermann Inc, Merck KGaA, Sinocare Inc, and Others.
Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.
This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -
The model will enable you to -
Not Applicable
Not Applicable
Not Applicable